SARS-CoV-2, the novel coronavirus strain which causes the pneumonia-like
illness COVID-19, originated in China and stemmed a worldwide pandemic
in early 2020. Testing is imperative for identifying active infection
(IgA and IgM) as well as past infection (IgG) and possible immunity.
Monobind offers qualitative assays for analysis of antibodies present in
serum or plasma.